No active infections requiring systemic antibiotic treatment (oral antibiotics are acceptable at the discretion of the treating physician)
Use of antibiotics to treat chronic infections within  days prior to first dose
Active systemic infections requiring antibiotics
Active infections requiring antibiotics, physician monitoring or recurrent fevers >.?F (.?C) associated with a clinical diagnosis of active infection
Active serious infections not controlled by antibiotics
Patients who have an active infection requiring systemic therapy are not eligible, except for uncomplicated urinary tract infections
Must have no ongoing active, uncontrolled infections (afebrile for >  hours off antibiotics)
Repeated infections requiring oral or i.v. antibiotics
Patient with active, uncontrolled infections (patients must be afebrile for >  hours off antibiotics).
Active or fungal infections requiring systemic treatment within  days prior to screening
Patients with active systemic infections requiring intravenous antibiotics within  week prior to enrollment
Has an active infection requiring systemic therapy (apart from cutaneous infections).
Active uncontrolled systemic infections (defined as infections causing fevers and infections requiring intravenous antibiotics when the intravenous antibiotics have been administered for less than  hours); active coagulation disorders or other major uncontrolled medical illnesses of the cardiovascular, respiratory, endocrine, renal, gastrointestinal, genitourinary or immune system; history of myocardial infarction; history of ventricular tachycardia or ventricular fibrillation; active cardiac arrhythmias (active atrial fibrillation is not allowed, but resolved atrial fibrillation is allowed); active obstructive or restrictive pulmonary disease; or active autoimmune diseases such as rheumatoid arthritis
No active infections requiring systemic antibiotics
Active uncontrolled systemic infections (defined as infections causing fevers and infections requiring intravenous antibiotics when intravenous antibiotics have been administered for less than  hours), active coagulation disorders or other major uncontrolled medical illnesses of the cardiovascular, respiratory, endocrine, renal, gastrointestinal, genitourinary or immune system, history of myocardial infarction, history of ventricular tachycardia or ventricular fibrillation, active cardiac arrhythmias (active atrial fibrillation is not allowed, resolved atrial fibrillation not requiring current treatment is allowed [anticoagulants count as current treatment]), active obstructive or restrictive pulmonary disease, active autoimmune diseases such as rheumatoid arthritis
Active HBV or HCV infections requiring therapy.
Active serious infections not controlled by antibiotics
Active serious infections not controlled by antibiotics
Histry of significant chronic or recurrent infections requiring treatment
Has an active infection requiring systemic therapy or history of repeated infections
Serious, active infections requiring treatment with IV antibiotics
All infections must be resolved and the patient must remain afebrile for seven days without antibiotics prior to being placed on study
Active systemic infections requiring intravenous antibiotics
Patients with known systemic infections requiring antibiotics or chronic maintenance/suppressive therapy
Patients with systemic infections requiring active therapy within  hours of lymphodepletion
Patients with active systemic infections requiring antibiotics or active hepatitis A, B, or C.
No active infections requiring systemic therapy
Active (acute or chronic) or uncontrolled severe infections requiring intravenous antibiotics
Patients who have active infections requiring therapy.
Patients with infections requiring intravenous (IV) antibiotic/antiviral therapy are not eligible for entry onto the study; patients on prophylactic antibiotics or antivirals are acceptable.
Severe infections necessitating use of antibiotics / antivirals during the screening period
Serious, active infections must be controlled; patients may be enrolled while still on antibiotics as long as clinical signs of active infection are absent
Serious, active infections requiring treatment with intravenous (IV) antibiotics
Active serious infections not controlled by antibiotics
Patients with active infections requiring systemic treatment.
Active systemic infections requiring intravenous antibiotics
Active infections requiring systemic antibiotics.
Active infections requiring systemic antibiotics.
Patients must be free of active infections requiring antibiotics, with the exception of uncomplicated urinary tract infections (UTIs)
Active uncontrolled serious infection or sepsis at study enrollment; patients receiving antibiotics for infections that are under control may be included in the study
Active infections prior to receiving study treatment or systemic infection requiring chronic maintenance or suppressive therapy
Active infections requiring antibiotics
Patients with systemic infections requiring antibiotics or chronic maintenance/suppressive therapy
Serious, active infections must be controlled; patients may be enrolled while still on antibiotics as long as clinical signs of active infection have resolved
Chronic or current active infections requiring systemic antibiotics, antifungals or antiviral therapy
Patients with important infections requiring antibiotics are INELIGIBLE, but patients who acquire minor infections while on the study may remain on the study
Active systemic infections requiring intravenous antibiotics
Patients with active systemic infections requiring antibiotics or chronic maintenance/suppressive therapy; once the infection in question has resolved and patient is off antimicrobial treatment, patients may participate
Active serious infections uncontrolled by antibiotics
Active infections requiring systemic therapy
Subject has known or suspected HIV or other active infections requiring acute or chronic treatment with systemic antibiotics. Conditions requiring topical antibiotics are acceptable.
Active serious infections not controlled by antibiotics
Active acute infection (i.e. currently treated with antibiotics); patients with chronic infections such as hepatitis B or C, mycobacterium avium or similar infections will be eligible provided they meet all other eligibility criteria